journal article·2023-03-20Open access

Quercetin- and caffeic acid-functionalized chitosan-capped colloidal silver nanoparticles: one-pot synthesis, characterization, and anticancer and antibacterial activities

Akif Hakan Kurt, Elif Berna Olutas, Fatma Avcioglu, Hamza Karakuş, Mehmet Ali Sungur, Cansu Kara Oztabag, Muhammet Yıldırım

Abstract

The presented study comprises the one-pot synthesis and the characterization of quercetin- and caffeic acid-functionalized chitosan-capped colloidal silver nanoparticles (Ch/Q- and Ch/CA-Ag NPs), and their antibacterial and anticancer activities. The formation of Ch/Q- and Ch/CA-Ag NPs has been confirmed by ultraviolet–visible (UV–vis) spectroscopy, Fourier-transform infrared (FTIR) spectroscopy, and transmission electron microscopy (TEM). The characteristic surface plasmon resonance (SPR) absorption band has been found at 417 and 424 nm for Ch/Q- and Ch/CA-Ag NPs, respectively. The formation of a chitosan shell comprising quercetin and caffeic acid, which surround the colloidal core Ag NPs, was confirmed by UV–vis, and FTIR analyses, and monitored by TEM microscopy. The size of nanoparticles has been determined as 11.2 and 10.3 nm for Ch/Q- and Ch/CA-Ag, respectively. The anticancer activity of Ch/Q- and Ch/CA-Ag NPs has been evaluated against U-118 MG (human glioblastoma) and ARPE-19 (human retinal pigment epithelium) cells. Both NPs showed anticancer activity, but Ch/Q-Ag NPs seemed to be more effective on cancer cell lines (U-118 MG) in comparison to healthy ones (ARPE-19). Furthermore, the antibacterial activity of Ch/Q- and Ch/CA-Ag NPs against Gram-negative ( P. aeruginosa and E. coli ) and Gram-positive ( S. aureus and S. epidermidis ) bacteria was determined, and dose-dependent antibacterial effects were found.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Gold and Silver Nanoparticles Synthesis and Applications · Laser-Ablation Synthesis of Nanoparticles

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (77)

Show source-provided references
1. 10.1016/j.diabres.2017.11.01810.1016/j.diabres.2017.11.018 ↗
2. 10.1088/0957-4484/18/28/28560410.1088/0957-4484/18/28/285604 ↗
3. 10.5402/2012/19572710.5402/2012/195727 ↗
4. 10.2174/138161282266616030715124110.2174/1381612822666160307151241 ↗
5. 10.1056/nejmoa130680110.1056/nejmoa1306801 ↗
6. 10.5772/intechopen.7561110.5772/intechopen.75611 ↗
7. 10.1007/s12010-015-1710-310.1007/s12010-015-1710-3 ↗
8. 10.1016/j.biomaterials.2019.04.02010.1016/j.biomaterials.2019.04.020 ↗
9. 10.1080/1120009x.2020.171350810.1080/1120009x.2020.1713508 ↗
10. 10.1016/j.addr.2009.09.00410.1016/j.addr.2009.09.004 ↗
11. 10.3390/md804096810.3390/md8040968 ↗
12. Struszczyk · 2001
13. 10.1016/s0147-5975(79)80054-710.1016/s0147-5975(79)80054-7 ↗
14. 10.1016/j.eurpolymj.2015.03.06610.1016/j.eurpolymj.2015.03.066 ↗
15. 10.1155/2012/63269810.1155/2012/632698 ↗
16. 10.1021/am300292v10.1021/am300292v ↗
17. 10.1016/j.jphotobiol.2006.01.00610.1016/j.jphotobiol.2006.01.006 ↗
18. 10.3390/nu803016710.3390/nu8030167 ↗
19. 10.1038/srep2404910.1038/srep24049 ↗
20. Lamson · Alternative Medicine Review · 2000 · 5 · 196
21. 10.1016/j.biopha.2018.02.04010.1016/j.biopha.2018.02.040 ↗
22. 10.1016/j.ijantimicag.2005.09.00210.1016/j.ijantimicag.2005.09.002 ↗
23. 10.1093/jn/137.5.120810.1093/jn/137.5.1208 ↗
24. 10.1021/jo035722y10.1021/jo035722y ↗
25. 10.1021/jm060912x10.1021/jm060912x ↗
26. 10.1248/bpb.27.114010.1248/bpb.27.1140 ↗
27. 10.1016/j.bmcl.2004.05.06110.1016/j.bmcl.2004.05.061 ↗
28. 10.1016/s0968-0896(01)00275-910.1016/s0968-0896(01)00275-9 ↗
29. 10.1007/s13197-014-1704-010.1007/s13197-014-1704-0 ↗
30. 10.1007/s11010-010-0655-710.1007/s11010-010-0655-7 ↗
31. 10.1016/j.ijpharm.2010.09.03510.1016/j.ijpharm.2010.09.035 ↗
32. 10.1016/j.tox.2005.09.01110.1016/j.tox.2005.09.011 ↗
33. 10.1016/j.antiviral.2009.05.00210.1016/j.antiviral.2009.05.002 ↗
34. 10.1186/1743-7075-6-3310.1186/1743-7075-6-33 ↗
35. 10.1021/nl034396z10.1021/nl034396z ↗
36. 10.1021/nn800596w10.1021/nn800596w ↗
37. 10.1002/jat.275810.1002/jat.2758 ↗
38. 10.1021/es103316q10.1021/es103316q ↗
39. 10.1016/j.micpath.2018.01.03810.1016/j.micpath.2018.01.038 ↗
40. 10.1021/acsami.5b1116010.1021/acsami.5b11160 ↗
41. 10.1002/anie.20120592310.1002/anie.201205923 ↗
42. 10.3390/nano809068110.3390/nano8090681 ↗
43. 10.1016/j.jcis.2016.08.00310.1016/j.jcis.2016.08.003 ↗
44. Faisal · Biointerface Research in Applied Chemistry · 2017 · 7 · 2286
45. 10.1111/j.1365-2672.2012.05253.x10.1111/j.1365-2672.2012.05253.x ↗
46. 10.1016/j.bcab.2020.10183810.1016/j.bcab.2020.101838 ↗
47. 10.1016/j.carres.2009.09.00110.1016/j.carres.2009.09.001 ↗
48. 10.15171/apb.2019.04810.15171/apb.2019.048 ↗
49. 10.1016/j.carbpol.2019.11507210.1016/j.carbpol.2019.115072 ↗
50. 10.1088/1361-6528/ac253610.1088/1361-6528/ac2536 ↗
51. 10.1007/s13205-019-1739-z10.1007/s13205-019-1739-z ↗
52. 10.1007/s10876-020-01947-910.1007/s10876-020-01947-9 ↗
53. 10.1088/2053-1591/aac2ef10.1088/2053-1591/aac2ef ↗
54. 10.1038/s41598-020-76726-710.1038/s41598-020-76726-7 ↗
55. 10.1002/pls2.1006910.1002/pls2.10069 ↗
56. 10.1093/neuonc/nos24710.1093/neuonc/nos247 ↗
57. Prema · European Journal of Biomedical and Pharmaceutical Sciences · 2015 · 2 · 855
58. 10.1016/j.jcis.2016.02.04310.1016/j.jcis.2016.02.043 ↗
59. 10.1016/j.carbpol.2018.07.07710.1016/j.carbpol.2018.07.077 ↗
60. 10.1007/s10876-019-01649-x10.1007/s10876-019-01649-x ↗
61. 10.1111/j.1469-0691.2006.01454.x10.1111/j.1469-0691.2006.01454.x ↗
62. 10.1039/c6qi00115g10.1039/c6qi00115g ↗
63. 10.1088/1468-6996/16/3/03500110.1088/1468-6996/16/3/035001 ↗
64. 10.3390/md1301014110.3390/md13010141 ↗
65. 10.1039/c3an36905f10.1039/c3an36905f ↗
66. 10.1007/s12161-020-01934-w10.1007/s12161-020-01934-w ↗
67. 10.1016/j.foodchem.2011.10.06310.1016/j.foodchem.2011.10.063 ↗
68. 10.1016/j.foodchem.2009.07.02310.1016/j.foodchem.2009.07.023 ↗
69. 10.1016/j.jcis.2014.06.03010.1016/j.jcis.2014.06.030 ↗
70. 10.3390/molecules1806685210.3390/molecules18066852 ↗
71. 10.1021/jf048396b10.1021/jf048396b ↗
72. 10.1038/s41420-022-01207-x10.1038/s41420-022-01207-x ↗
73. 10.1039/c4cs00487f10.1039/c4cs00487f ↗
74. 10.1016/j.colsurfa.2023.13093510.1016/j.colsurfa.2023.130935 ↗
75. 10.14715/cmb/2021.67.5.2110.14715/cmb/2021.67.5.21 ↗
76. 10.56042/ijeb.v59i02.4572710.56042/ijeb.v59i02.45727 ↗
77. 10.7717/peerj.571110.7717/peerj.5711 ↗